|
Sign In to gain access to subscriptions and/or personal tools.
|
Net Health Benefits
A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis
Aaron A. Stinnett
John Mullahy
In recent years, considerable attention has been devoted to the development of sta tistical methods for the analysis of uncertainty in cost-effectiveness (CE) analysis, with a focus on situations in which the analyst has patient-level data on the costs and health effects of alternative interventions. To date, discussions have focused almost exclu sively on addressing the practical challenges involved in estimating confidence inter vals for CE ratios. However, the general approach of using confidence intervals to convey information about uncertainty around CE ratio estimates suffers from theoretical limitations that render it inappropriate in many situations. The authors present an al ternative framework for analyzing uncertainty in the economic evaluation of health interventions (the "net health benefits" approach) that is more broadly applicable and that avoids some problems of prior methods. This approach offers several practical and theoretical advantages over the analysis of CE ratios, is straightforward to apply, and highlights some important principles in the theoretical underpinnings of CE anal ysis. Key words: cost-effectiveness; net health benefits; uncertainty. (Med Decis Mak ing 1998;18 suppl:S68-S80)
Medical Decision Making, Vol. 18, No. 2,
S68-S80 (1998)
DOI: 10.1177/0272989X9801800209
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
M. D. Stevenson, J. E. Oakley, M. Lloyd Jones, A. Brennan, J. E. Compston, E. V. McCloskey, and P. L. Selby
The Cost-Effectiveness of an RCT to Establish Whether 5 or 10 Years of Bisphosphonate Treatment Is the Better Duration for Women With a Prior Fracture
Med Decis Making,
November 1, 2009;
29(6):
678 - 689.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Conti and K. Claxton
Dimensions of Design Space: A Decision-Theoretic Approach to Optimal Research Design
Med Decis Making,
November 1, 2009;
29(6):
643 - 660.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. E. Simon, E. J. Ludman, and C. M. Rutter
Incremental Benefit and Cost of Telephone Care Management and Telephone Psychotherapy for Depression in Primary Care
Arch Gen Psychiatry,
October 1, 2009;
66(10):
1081 - 1089.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Sany, J.-D. Cohen, C. Combescure, M.-C. Bozonnat, F. Roch-Bras, G. Lafon, and J.-P. Daures
Medico-economic evaluation of infliximab in rheumatoid arthritis--prospective French study of a cohort of 635 patients monitored for two years
Rheumatology,
October 1, 2009;
48(10):
1236 - 1241.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. J. F. van der Sluis, J. L. Bosch, T. Terkivatan, R. A. de Man, J. N. M. IJzermans, and M. G. M. Hunink
Hepatocellular Adenoma: Cost-effectiveness of Different Treatment Strategies
Radiology,
September 1, 2009;
252(3):
737 - 746.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Hoomans, J. L. Severens, S. M. A. A. Evers, and A. J. H. A. Ament
Value for Money in Changing Clinical Practice: Should Decisions about Guidelines and Implementation Strategies Be Made Sequentially or Simultaneously?
Med Decis Making,
March 1, 2009;
29(2):
207 - 216.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Richardson, K. Bloor, J. Williams, I. Russell, D. Durai, W. Y. Cheung, A. Farrin, and S. Coulton
Cost effectiveness of nurse delivered endoscopy: findings from randomised multi-institution nurse endoscopy trial (MINuET)
BMJ,
February 10, 2009;
338(feb10_1):
b270 - b270.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Griffin, K. Claxton, and M. Sculpher
Decision analysis for resource allocation in health care
J Health Serv Res Policy,
October 1, 2008;
13(suppl_3):
23 - 30.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Sutton, N. J. Cooper, S. Goodacre, and M. Stevenson
Integration of Meta-analysis and Economic Decision Modeling for Evaluating Diagnostic Tests
Med Decis Making,
September 1, 2008;
28(5):
650 - 667.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. Sharifi, H. Sharifi, S. Morshed, K. Bozic, and M. Diab
Cost-Effectiveness Analysis of Periacetabular Osteotomy
J. Bone Joint Surg. Am.,
July 1, 2008;
90(7):
1447 - 1456.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Castelnuovo, P. Cross, S. Mt-Isa, A. Spencer, M. Underwood, and on behalf of the TOIB study team
Cost-effectiveness of advising the use of topical or oral ibuprofen for knee pain; the TOIB study [ISRCTN: 79353052]
Rheumatology,
July 1, 2008;
47(7):
1077 - 1081.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Philips, K. Claxton, and S. Palmer
The Half-Life of Truth: What Are Appropriate Time Horizons for Research Decisions?
Med Decis Making,
June 1, 2008;
28(3):
287 - 299.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. W. Timbie, J. P. Newhouse, M. B. Rosenthal, and S.-L. T. Normand
A Cost-Effectiveness Framework for Profiling the Value of Hospital Care
Med Decis Making,
June 1, 2008;
28(3):
419 - 434.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G Richardson, A Kennedy, D Reeves, P Bower, V Lee, E Middleton, C Gardner, C Gately, and A Rogers
Cost effectiveness of the Expert Patients Programme (EPP) for patients with chronic conditions
J Epidemiol Community Health,
April 1, 2008;
62(4):
361 - 367.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Eckermann, A. Briggs, and A. R. Willan
Health Technology Assessment in the Cost-Disutility Plane
Med Decis Making,
March 1, 2008;
28(2):
172 - 181.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. Groot Koerkamp, J. J. Nikken, E. H. Oei, T. Stijnen, A. Z. Ginai, and M. G. M. Hunink
Value of Information Analysis Used to Determine the Necessity of Additional Research: MR Imaging in Acute Knee Trauma as an Example
Radiology,
February 1, 2008;
246(2):
420 - 425.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Fenwick, K. Claxton, and M. Sculpher
The Value of Implementation and the Value of Information: Combined and Uneven Development
Med Decis Making,
January 1, 2008;
28(1):
21 - 32.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. A. Rosenheck, D. L. Leslie, J. L. Sindelar, E. A. Miller, P. N. Tariot, K. S. Dagerman, S. M. Davis, B. D. Lebowitz, P. Rabins, J. K. Hsiao, et al.
Cost-Benefit Analysis of Second-Generation Antipsychotics and Placebo in a Randomized Trial of the Treatment of Psychosis and Aggression in Alzheimer Disease
Arch Gen Psychiatry,
November 1, 2007;
64(11):
1259 - 1268.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. H. A. Ament, M. W. A. Hubben, P. E. Verweij, R. de Groot, A. Warris, J. P. Donnelly, J. v. t Wout, and J. L. Severens
Economic evaluation of targeted treatments of invasive aspergillosis in adult haematopoietic stem cell transplant recipients in the Netherlands: a modelling approach
J. Antimicrob. Chemother.,
August 1, 2007;
60(2):
385 - 393.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Noyes, A. W. Dick, and R. G. Holloway
The Implications of Using US-Specific EQ-5D Preference Weights for Cost-Effectiveness Evaluation
Med Decis Making,
May 1, 2007;
27(3):
327 - 334.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. D. Frick, E. W. Gower, J. H. Kempen, and J. L. Wolff
Economic Impact of Visual Impairment and Blindness in the United States
Arch Ophthalmol,
April 1, 2007;
125(4):
544 - 550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Groot Koerkamp, M.G. M. Hunink, T. Stijnen, J. K. Hammitt, K. M. Kuntz, and M. C. Weinstein
Limitations of Acceptability Curves for Presenting Uncertainty in Cost-Effectiveness Analysis
Med Decis Making,
March 1, 2007;
27(2):
101 - 111.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Schon, S. W. Blume, K. Niebauer, C. S. Hollenbeak, and G. de Lissovoy
Increasing the Use of Arteriovenous Fistula in Hemodialysis: Economic Benefits and Economic Barriers
Clin. J. Am. Soc. Nephrol.,
March 1, 2007;
2(2):
268 - 276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. E. Simon, W. J. Katon, E. H. B. Lin, C. Rutter, W. G. Manning, M. Von Korff, P. Ciechanowski, E. J. Ludman, and B. A. Young
Cost-effectiveness of Systematic Depression Treatment Among People With Diabetes Mellitus
Arch Gen Psychiatry,
January 1, 2007;
64(1):
65 - 72.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P A A Struijs, I B C Korthals-de Bos, M W van Tulder, C N van Dijk, L M Bouter, W J J Assendelft, and B M Pluim
Cost effectiveness of brace, physiotherapy, or both for treatment of tennis elbow * Commentary
Br. J. Sports Med.,
July 1, 2006;
40(7):
637 - 643.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Katon, J. Unutzer, M.-Y. Fan, J. W. Williams Jr, M. Schoenbaum, E. H.B. Lin, and E. M. Hunkeler
Cost-Effectiveness and Net Benefit of Enhanced Treatment of Depression for Older Adults With Diabetes and Depression
Diabetes Care,
February 1, 2006;
29(2):
265 - 270.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. Heijenbrok-Kal, E. Buskens, P. J. Nederkoorn, Y. van der Graaf, and M. G. M. Hunink
Optimal Peak Systolic Velocity Threshold at Duplex US for Determining the Need for Carotid Endarterectomy: A Decision Analytic Approach
Radiology,
December 21, 2005;
(2005)
2381041078.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
F. L. Lynch, M. Hornbrook, G. N. Clarke, N. Perrin, M. R. Polen, E. O'Connor, and J. Dickerson
Cost-effectiveness of an Intervention to Prevent Depression in At-Risk Teens
Arch Gen Psychiatry,
November 1, 2005;
62(11):
1241 - 1248.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Ginnelly, M. Sculpher, C. Bojke, I. Roberts, A. Wade, and C. Diguiseppi
Determining the cost effectiveness of a smoke alarm give-away program using data from a randomized controlled trial
Eur J Public Health,
October 1, 2005;
15(5):
448 - 453.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Aujesky, K. J. Smith, J. Cornuz, and M. S. Roberts
Cost-Effectiveness of Low-Molecular-Weight Heparin for Treatment of Pulmonary Embolism
Chest,
September 1, 2005;
128(3):
1601 - 1610.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. G. Thompson and R. M. Nixon
How Sensitive Are Cost-Effectiveness Analyses to Choice of Parametric Distributions?
Med Decis Making,
July 1, 2005;
25(4):
416 - 423.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Y.-C. T. Shih, S. Han, and S. B. Cantor
Impact of Generic Drug Entry on Cost-Effectiveness Analysis
Med Decis Making,
January 1, 2005;
25(1):
71 - 80.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. C. Gelijns, L. D. Brown, C. Magnell, E. Ronchi, and A. J. Moskowitz
Evidence, Politics, And Technological Change
Health Aff.,
January 1, 2005;
24(1):
29 - 40.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. Johnson-Masotti, P. W. Laud, R. G. Hoffmann, M. J. Hayat, and S. D. Pinkerton
A Bayesian Approach to Net Health Benefits: An Illustration and Application to Modeling HIV Prevention
Med Decis Making,
November 1, 2004;
24(6):
634 - 653.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Noyes, A. W. Dick, R. G. Holloway, and Parkinson Study Group
Pramipexole v. Levodopa as Initial Treatment for Parkinson's Disease: A Randomized Clinical-Economic Trial
Med Decis Making,
October 1, 2004;
24(5):
472 - 485.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. Cook, M. Drummond, and J. F Heyse
Economic endpoints in clinical trials
Statistical Methods in Medical Research,
April 1, 2004;
13(2):
157 - 176.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. Wonderling, A. J Vickers, R. Grieve, and R. McCarney
Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care
BMJ,
March 27, 2004;
328(7442):
747.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. E. Ades, G. Lu, and K. Claxton
Expected Value of Sample Information Calculations in Medical Decision Modeling
Med Decis Making,
March 1, 2004;
24(2):
207 - 227.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. DUNN, M. MIRANDOLA, F. AMADDEO, and M. TANSELLA
Describing, explaining or predicting mental health care costs: a guide to regression models: Methodological review
The British Journal of Psychiatry,
November 1, 2003;
183(5):
398 - 404.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Rosenheck, W. Kasprow, L. Frisman, and W. Liu-Mares
Cost-effectiveness of Supported Housing for Homeless Persons With Mental Illness
Arch Gen Psychiatry,
September 1, 2003;
60(9):
940 - 951.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. S. Liem, M. C. J. M. Kock, J. N. M. Ijzermans, W. Weimar, K. Visser, and M.G. M. Hunink
Living Renal Donors: Optimizing the Imaging Strategy--Decision- and Cost-effectiveness Analysis
Radiology,
January 1, 2003;
226(1):
53 - 62.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A O'Hagan and J W Stevens
Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies
Statistical Methods in Medical Research,
December 1, 2002;
11(6):
469 - 490.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G Parmigiani
Measuring uncertainty in complex decision analysis models
Statistical Methods in Medical Research,
December 1, 2002;
11(6):
513 - 537.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A R Willan, D Y Lin, R J Cook, and E B Chen
Using inverse-weighting in cost-effectiveness analysis with censored data
Statistical Methods in Medical Research,
December 1, 2002;
11(6):
539 - 551.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. E. Ades and S. Cliffe
Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty
Med Decis Making,
August 1, 2002;
22(4):
359 - 371.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. P. Johnson-Masotti, P. W. Laud, R. G. Hoffmann, M. J. Hayat, and S. D. Pinkerton
Probabilistic Cost-Effectiveness Analysis of HIV Prevention: Comparing a Bayesian Approach With Traditional Deterministic Sensitivity Analysis
Eval Rev,
August 1, 2001;
25(4):
474 - 502.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. G. M. Hunink
In Search of Tools to Aid Logical Thinking and Communicating about Medical Decision Making
Med Decis Making,
August 1, 2001;
21(4):
267 - 277.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. O'Hagan and J. W. Stevens
Bayesian Assessment of Sample Size for Clinical Trials of Cost-Effectiveness
Med Decis Making,
May 1, 2001;
21(3):
219 - 230.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. S. R. Muradin and M. G. Myriam Hunink
Cost and Patency Rate Targets for the Development of Endovascular Devices to Treat Femoropopliteal Arterial Disease
Radiology,
February 1, 2001;
218(2):
464 - 469.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
E. F. Halpern, M. C. Weinstein, M. G.M. Hunink, and G. S. Gazelle
Representing Both First- and Second-order Uncertainties by Monte Carlo Simulation for Groups of Patients
Med Decis Making,
July 1, 2000;
20(3):
314 - 322.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. A. Craig, M. A. Black, and P. P. Sendi
Uncertainty in Decision Models Analyzing Cost-Effectiveness
Med Decis Making,
January 1, 2000;
20(1):
135 - 136.
[PDF]
|
|
|
|
|
|
|
M. G.M. Hunink, A. A. Stinnett, T. Stijnen, and M. C. Weinstein
Letter
Med Decis Making,
January 1, 2000;
20(1):
136 - 137.
[PDF]
|
|
|
|
|
|
|
A E Ades, M J Sculpher, D M Gibb, R Gupta, and J Ratcliffe
Cost effectiveness analysis of antenatal HIV screening in United Kingdom
BMJ,
November 6, 1999;
319(7219):
1230 - 1234.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. G.M. Hunink, K. M. Kuntz, K. E. Fleischmann, and T. J. Brady
Noninvasive Imaging for the Diagnosis of Coronary Artery Disease: Focusing the Development of New Diagnostic Technology
Ann Intern Med,
November 2, 1999;
131(9):
673 - 680.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Laska, M. Meisner, and C. Siegel
Power and Sample Size in Cost- Effectiveness Analysis
Med Decis Making,
August 1, 1999;
19(3):
339 - 343.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. F. Heitjan, A. J. Moskowitz, and W. Whang
Problems with Interval Estimates of the Incremental Cost--Effectiveness Ratio
Med Decis Making,
January 1, 1999;
19(1):
9 - 15.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. A. Stinnett
Is It Really So Bad to be Unambiguously Ineificient?: The Role of Dominance in Stochastic Cost--Effectiveness Analysis
Med Decis Making,
January 1, 1999;
19(1):
102 - 103.
[PDF]
|
|
|
|
|
